Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S9VL
|
||||
Former ID |
DIB020352
|
||||
Drug Name |
MGS0039
|
||||
Synonyms |
MGS-0039; MGS 0039
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [538873] | ||
Structure |
Download2D MOL |
||||
Formula |
C15H14Cl2FNO5
|
||||
InChI |
InChI=1S/C15H14Cl2FNO5/c16-8-2-1-6(3-9(8)17)5-24-10-4-7-11(14(7,18)12(20)21)15(10,19)13(22)23/h1-3,7,10-11H,4-5,19H2,(H,20,21)(H,22,23)/t7-,10-,11+,14-,15+/m1/s1
|
||||
InChIKey |
LFAGGDAZZKUVKO-JAGWWQSPSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Metabotropic glutamate receptor3 | Target Info | Antagonist | [527175] | |
Metabotropic glutamate receptor 2 | Target Info | Antagonist | [527175] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Ionotropic glutamate receptor pathway | |||||
Metabotropic glutamate receptor group II pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Metabotropic glutamate receptor group II pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.